Evidence map›Paper›PMID 38216288›Full record

Observational studyRMD open2024

Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets.

Enrico De Lorenzis, Vishal Kakkar, Stefano Di Donato, Michelle Wilson, Theresa Barnes, Chris Denton, Emma Derrett-Smith, Karen Douglas, Philip Helliwell, Ariane L Herrick and 6 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06776575 (Musculoskeletal Ultrasound and Electrophysiological Evaluation of the Hand in Patients With Systemic Sclerosis), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06776575 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Musculoskeletal Ultrasound and Electrophysiological Evaluation of the Hand in Patients With Systemic Sclerosis: Relation to Hand Dysfunction and Quality of Life

TypeobservationalSponsorAssiut UniversityRan2025 to 2028Enrolled45ConditionsScleroderma, Hand Functionality, Quality of Life (QOL)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Enrico De LorenzisLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.ORCID 0000-0001-9819-105X
Vishal KakkarLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Stefano Di DonatoLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Michelle WilsonLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Theresa BarnesDepartment of Rheumatology, Countess of Chester Hospital NHS Foundation Trust, Liverpool, UK.
Chris DentonDepartment of Rheumatology, Royal Free London NHS Foundation Trust, London, UK.
Emma Derrett-SmithDepartment of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Karen DouglasDepartment of Rheumatology, The Dudley Group NHS Foundation Trust, Dudley, UK.
Philip HelliwellDepartment of Rheumatology, St. Luke's Hospital, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.ORCID 0000-0002-4155-9105
Ariane L HerrickCentre for Musculoskeletal Research, The University of Manchester, Salford Royal NHS Foundation Trust,Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0003-4941-7926
Benazir SaleemLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.ORCID 0000-0001-8719-7800
Muhammad NisarDepartment of Rheumatology, Luton & Dunstable University Hospital NHS Foundation Trust, Luton, UK.
Catherine MorleyDepartment of Rheumatology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Lorraine GreenLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Begonya Alcacer-PitarchLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.ORCID 0000-0002-2208-444X
Francesco Del GaldoLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK f.delgaldo@leeds.ac.uk.ORCID 0000-0002-8528-2283
University of Leeds · GBCountess of Chester Hospital NHS Foundation Trust · GBDudley Group NHS Foundation Trust · GBLuton and Dunstable University Hospital NHS Foundation Trust · GBManchester Academic Health Science Centre · GBRoyal Free London NHS Foundation Trust · GBSouth Tyneside and Sunderland NHS Foundation Trust · GBSt. Luke's Hospital · GBUniversità Cattolica del Sacro Cuore · ITUniversity Hospitals Birmingham NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHand involvement is an early manifestation of systemic sclerosis (SSc), culprit of diagnosis and classification, and recognised major driver of disability. Impairment of hand function burdens both limited and diffuse cutaneous subsets and therefore could be targeted as 'basket' endpoint in SSc. Nevertheless, its natural history in current standard of care is not well characterised, limiting the design of targeted trials. The aim of this study is to describe prevalence, natural history and clinical factors associated with hand function deterioration in a longitudinal, multicentre, observational SSc cohort.

methodsHand function was captured through the validated Cochin Hand Function Scale in patients consecutively enrolled in a multicentre observational study and observed over 24 months. Minimal clinically important differences and patient acceptable symptom state were analysed as previously described.

resultsThree hundred and ninety-six consecutive patients were enrolled from 10 centres; 201 with complete follow-up data were included in the analysis. Median (IQR) disease duration was 5 (2-11) years. One hundred and five (52.2%) patients reported clinically significant worsening. Accordingly, the proportion of patients reporting unacceptable hand function increased over 2 years from 27.8% to 35.8% (p<0.001). Least absolute shrinkage and selection operator analysis identified male gender, disease subset, Raynaud's Condition Score, tenosynovitis and pain, as some of the key factors associated with worsening hand involvement.

conclusionsHand function deteriorates over time in more than 50% of SSc patients despite available therapies. The analysis of factors associated with hand function worsening supports the involvement of both inflammation, vascular and fibrotic processes in hand involvement, making it a hallmark clinical manifestation of SSc. Our data are poised to inform the design of intervention studies to target this major driver of disability in SSc.

Indexed as

Scleroderma, SystemicHandHumansMaleOutcome Assessment, Health CarePatient Reported Outcome MeasuresSystemic Sclerosis

Identifiers

PMID38216288
PMCPMC10806527
OpenAlexW4390818142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.